Invenomic Capital Management LP is a large advisory firm based in Boston. It manages $236.48 million of regulatory assets for 2 client accounts. It has been registered with the SEC as an adviser since 2017 and has operated in the jurisdiction of Massachusetts.
Invenomic Capital Management provides portfolio management for investment companies and portfolio management for pooled investment vehicles. It doesn't provide financial planning services to its clients. On top of advisory services, the firm doesn't engage in other business activities.
The assets under management (AUM) of Invenomic Capital Management LP is $236.48 million, all of which is managed in discretionary accounts. The firm's AUM has grown by 846% since the beginning of its operation, and $16.78 million of the total AUM is attributable to clients outside of the United States.
The advisory firm has several streams of revenue. Clients pay Invenomic Capital Management LP for their services and products based on a percentage of assets under management and performance-based fees. The adviser charges an additional fee when a set benchmark is outperformed. These fees don’t include brokerage commissions, interest, taxes, and other account expenses.
The firm provides services to investment companies and pooled investment vehicles. The largest group of clients of Benjamin Robert Deschaine is investment companies with 1 clients and $219.7 million of assets under management. Among the 8 most similar advisory firms, Invenomic Capital Management has the highest percentage of investment companies out of all clients.
The amount of regulatory assets under management is $236.48 million for 2 clients. 50% of the firm’s clients are foreign persons or businesses.
Invenomic Capital Management also advises several private funds. Namely, one hedge fund. The minimum investment commitment required of non-related persons is $1,000,000 for each fund.
The company employs 12 people that are either part- or full-time employees. 42 percent of the employees work as investment advisers or researchers. No employees are registered as investment adviser representatives with the state securities authorities.
There isn’t anyone with the role of looking for and bringing in new clients on behalf of the firm. The firm doesn’t compensate employees in addition to the salary for bringing in new clients. Employees don’t receive compensation from other entities for client referrals.
Benjamin Robert Deschaine has been acting as President since 1 Jul 2019. Balter Capital Management Llc joined the executive team most recently as the Limited Partner.
The principal office where Invenomic Capital Management LP performs its advisory services is located at 211 Congress St, Boston, MA 02110, which is also the mailing address of the firm. It doesn’t run an office outside of the United States.
You can reach the main office by calling the phone number 617-729-2323. The normal business hours are 9:00 am to 5:00 pm on Monday - Friday. You can find more information about the New York firm at invenomic.com.